Clinical Trials Logo

Clinical Trial Summary

Determine the PK and safety and tolerability of aztreonam-avibactam (ATM-AVI) in the treatment of hospitalized adults with cIAI


Clinical Trial Description

A Phase IIa prospective, open-label, multicenter study to determine the pharmacokinetics (PK) and safety and tolerability of aztreonam-avibactam (ATM-AVI) for the treatment of complicated Intra-Abdominal Infections (cIAIs) in hospitalized adults. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02655419
Study type Interventional
Source Pfizer
Contact
Status Completed
Phase Phase 2
Start date May 19, 2016
Completion date October 26, 2017